No Extra Vaccine Dose Needed For JN.1 Subvariant, Says Covid Panel Chief
NDTV
Dr NK Arora asserted that various subvariants of Omicron have been reported but none of them have increased severity.
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present. #WATCH | On Covid-19 new variant Jn.1, Dr NK Arora, Chairman, INSACOG says, " Within India...from October last week and then till now in last 8 weeks, we have seen 22 cases...there is no evidence that it is spreading very rapidly...Jn.1 is less than 1% of all the isolates so far.… pic.twitter.com/fPyLgoPJrQ
Speaking to ANI about the current situation in the country, Dr Arora said, "I would say prevention is required for all those who are 60 years of age or older, who are likely to have comorbidities and those who are on drugs that suppress our immunity, like cancer patients. If they have not taken precaution so far, then they are advised to take precaution; otherwise, there is no need for any additional doses."
The INSACOG chief asserted that various subvariants of Omicron have been reported but none of them have increased severity.
